The results of this analysis showed a strong and constant PAR5 downregulation in ATC tissues, whereas no significant changes were observed in PTC samples, meaning that PAR5 downregulation is associated with the highly malignant phenotype also in thyroid cancer. The gene discussed is PWAR5; the disease is thyroid gland carcinoma.